While SLC45A3′s function in PAH is not yet elucidated, KCNK3 inhibitions leads to increased proliferation, inflammation and subsequent vasoconstriction of the pulmonary artery [183]. The gene discussed is SLC45A3; the disease is pulmonary arterial hypertension.